Driven Brands Holdings Inc. to Host Second Quarter Earnings Call on August 5, 2025
The call will be available by webcast and can be accessed by visiting the Company's Investor Relations website at investors.drivenbrands.com. A replay of the call will be available for at least three months.
About Driven Brands
Driven Brands™, headquartered in Charlotte, NC, is the largest automotive services company in North America, providing a range of consumer and commercial automotive services, including paint, collision, glass, vehicle repair, oil change, maintenance, and car wash. Driven Brands is the parent company of some of North America's leading automotive service businesses including Take 5 Oil Change®, Meineke Car Care Centers®, Maaco®, 1-800-Radiator & A/C®, Auto Glass Now®, and CARSTAR®. Driven Brands has approximately 4,800 locations across the United States and 13 other countries, and services tens of millions of vehicles annually. Driven Brands' network generates approximately $2.0 billion in annual revenue from approximately $6.1 billion in system-wide sales.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250722655909/en/
Contacts
Shareholder/Analyst inquiries:Dawn FrancfortICR, Inc.investors@drivenbrands.com (203) 682-8200
Media inquiries:Taylor Blanchardtaylor.blanchard@drivenbrands.com (704) 644-8129
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025
REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial results for the second quarter of 2025 on Wednesday, August 6, 2025, after market close. At 4:30 p.m. ET that day (1:30 p.m. PT), members of Revolution Medicines' senior management team will host a webcast to discuss the financial results for the quarter and provide an update on corporate progress. To listen to the live webcast, or access the archived webcast, please visit: Following the live webcast, a replay will be available on the company's website for at least 14 days. About Revolution Medicines, Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; and zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, are currently in clinical development. The company anticipates that RMC-5127, a RAS(ON) G12V-selective inhibitor, will be its next RAS(ON) inhibitor to enter clinical development. Additional development opportunities in the company's pipeline focus on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C). For more information, please visit and follow us on LinkedIn. Revolution Medicines Media & Investor Contact:media@
Yahoo
8 minutes ago
- Yahoo
Board Declares Quarterly Dividend and Elects New Officer
WESTMINSTER, Colo., July 30, 2025 /PRNewswire/ -- Ball Corporation's (NYSE: BALL) board of directors (the "Board") today declared a cash dividend of 20 cents per share, payable September 16, 2025, to shareholders of record as of September 2, 2025. The Board also elected Edmund "Ted" Doering to serve as Chief Information Officer (CIO) of the corporation. Ted recently joined Ball to succeed Brian Gabbard, who is planning to retire from the company at the end of September. Ted brings more than three decades of global IT leadership experience, most recently serving as executive vice president and CIO at Berry Global. Before joining Berry, Ted was Chief Digital Officer at Emerson Electric and CIO of Emerson Automation Solutions. Ted has deep expertise in driving value creation, delivery execution and enterprise risk management. Conference Call Details Ball will announce its second quarter 2025 earnings on Tuesday, August 5, 2025 before trading begins on the New York Stock Exchange. At 9 a.m. Mountain Time on that day (11 a.m. Eastern Time), Ball will hold its regular quarterly conference call on the company's results and performance. Please use the following URL to join via webcast: To participate in the live call Q&A session, North American callers should use the following number, 877-497-9071. International callers should use the following number, +1 201-689-8727. For those unable to listen to the live call, a taped replay and transcript of the event will be available within 48 hours on Ball's website at under "Financial Results." About Ball Corporation Ball Corporation supplies innovative, sustainable aluminum packaging solutions for beverage, personal care and household products customers. Ball Corporation employs 16,000 people worldwide and reported 2024 net sales of $11.80 billion, which excludes the divested aerospace business. For more information, visit or connect with us on LinkedIn or Instagram. View original content to download multimedia: SOURCE Ball Corporation Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 minutes ago
- Yahoo
Everest Group: Q2 Earnings Snapshot
HAMILTON, Bermuda (AP) — HAMILTON, Bermuda (AP) — Everest Group, Ltd. (EG) on Wednesday reported second-quarter net income of $680 million. The Hamilton, Bermuda-based company said it had net income of $16.10 per share. Earnings, adjusted for non-recurring costs, were $17.36 per share. The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $15.14 per share. The reinsurance company posted revenue of $4.49 billion in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $4.4 billion. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on EG at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
